Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine.

MLA

Teng, Xindong, et al. “Immunogenicity and Protective Efficacy of DMT Liposome-Adjuvanted Tuberculosis Subunit CTT3H Vaccine.” Human Vaccines & Immunotherapeutics, vol. 11, no. 6, 2015, pp. 1456–64. EBSCOhost, https://doi.org/10.1080/21645515.2015.1037057.

APA

Teng, X., Tian, M., Li, J., Tan, S., Yuan, X., Yu, Q., Jing, Y., Zhang, Z., Yue, T., Zhou, L., & Fan, X. (2015). Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine. Human Vaccines & Immunotherapeutics, 11(6), 1456–1464. https://doi.org/10.1080/21645515.2015.1037057

Chicago

Teng, Xindong, Maopeng Tian, Jianrong Li, Songwei Tan, Xuefeng Yuan, Qi Yu, Yukai Jing, et al. 2015. “Immunogenicity and Protective Efficacy of DMT Liposome-Adjuvanted Tuberculosis Subunit CTT3H Vaccine.” Human Vaccines & Immunotherapeutics 11 (6): 1456–64. doi:10.1080/21645515.2015.1037057.